Clinical Trials Logo

Migraine clinical trials

View clinical trials related to Migraine.

Filter by:

NCT ID: NCT02483585 Completed - Migraine Clinical Trials

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention

ARISE
Start date: July 20, 2015
Phase: Phase 3
Study type: Interventional

To evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days, in adults with episodic migraine.

NCT ID: NCT02472418 Completed - Migraine Clinical Trials

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Start date: June 5, 2015
Phase: Phase 2
Study type: Interventional

Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.

NCT ID: NCT02468622 Completed - Migraine Clinical Trials

Transcriptomic and Biochemical Changes During a Migraine Attack

Start date: August 2015
Phase:
Study type: Observational

Despite the fact that migraine is a common disorder, the pathogenesis is still not fully elucidated. Studying transcriptomic and biochemical changes during induced and spontaneous migraine-attacks will enhance our understanding and may point to new targets for drug development.

NCT ID: NCT02458326 Recruiting - Fibromyalgia Clinical Trials

Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine

Start date: April 2015
Phase: Phase 1
Study type: Interventional

Fibromyalgia and migraine are diseases with high prevalence in women between the age group of 30-60 years, which seem to share the same pathophysiological mechanism; both originate from neuroendocrine disorders of the hypothalamic-pituitary axis in the central nervous system, and are therefore closely related. In addition to the strong relationship with migraine, fibromyalgia can also be associated with sleep disorders, chronic fatigue and psychological disorders. The combination of these factors decreases the quality of life and contributes to increased sedentary this population. It is known that physical exercise promotes positive changes in pain pathophysiological pathway to increase the release of endorphins neuroendógenas, improving the symptoms of fibromyalgia. The objective of this study is to analyze whether the application of an aerobic exercise program may result in the reduction of the frequency, duration and intensity of migraine attacks in women with fibromyalgia. For this, a clinical trial will be conducted randomized double-blind clinical trial comparing two groups of women diagnosed with fibromyalgia and migraine. Initially, all answer questionnaires assessing quality of life, impact of headache, level of depression and anxiety, sleep quality, physical activity level, and; will be held ergospirometry for research in exercise tolerance. The experimental group will implement the protocol consists of heating, aerobic exercise according to the heart rate established for training by spirometry and slowdown; and the control group will hold the heat on low speed and heart rate will next baseline. Both groups will be followed for 12 weeks, with a frequency of three weekly meetings lasting 30 minutes and re-evaluated every 4 weeks. At the end of the protocol, the groups will have their results were compared and statistically analyzed.

NCT ID: NCT02456740 Completed - Migraine Clinical Trials

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

STRIVE
Start date: July 17, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days.

NCT ID: NCT02446275 Completed - MIGRAINE Clinical Trials

Efficacy of Manual Therapy in Migraine

MTHDIQMi
Start date: January 2014
Phase: N/A
Study type: Interventional

Objective: The aim of this study was to determine the efficacy of suboccipital inhibitory manual therapy treatment in migraine compared to treatment based on Myofascial Trigger Points (MTrPs) and their stretching, often being hypersensitive in patients with migraine. Material and methods: 27 patients in two groups participated in the study: a) the control group received combined techniques based on MTrPs and bilateral stretching in the trapezius and sternocleidomastoid muscle (SCM); b) the experimental group was applied the same techniques as those applied in the control group plus suboccipital inhibition. The treatment lasted for 8 weeks and the impact, disability and quality of life were assessed in both groups.

NCT ID: NCT02443519 Completed - Migraine Clinical Trials

Bronx MBCT-Migraine

BMBCT-M
Start date: July 2015
Phase: N/A
Study type: Interventional

This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.

NCT ID: NCT02425696 Completed - Migraine Clinical Trials

Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population

Start date: June 2015
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of the study is to evaluate the prevalence and extent of right-to-left shunt (RLS) in Chinese migraineurs, and the morbidity of silent cerebral infarction in migraineurs.

NCT ID: NCT02411513 Completed - Migraine Clinical Trials

Acute Treatment of Migraine Using the CEFALY Device

Start date: April 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the efficacy of e-TNS with the Cefaly® device as an acute treatment for a migraine attack. This open clinical trial will study the acute treatment of migraine using the Cefaly® device, prior to development of a sham-controlled trial.

NCT ID: NCT02403687 Completed - Migraine Clinical Trials

Prospective Analgesic Compound Efficacy (PACE) Study

PACE
Start date: June 2015
Phase: N/A
Study type: Observational [Patient Registry]

A 24-week observational prospective study on the efficacy of topical non-steroidal anti-inflammatory drugs for the relief of pain.